Literature DB >> 1657362

Flow cytometric analysis of the nuclear DNA content of hepatoblastoma.

Y Hata1, H Ishizu, K Ohmori, H Hamada, F Sasaki, J Uchino, K Inoue, H Naitoh, M Fujita, T Kobayashi.   

Abstract

The nuclear DNA content of 15 hepatoblastoma cases was determined in paraffin-embedded tissues by flow cytometry. The DNA index (DI) was calculated, and the ploidy pattern of nuclear DNA was estimated. The correlation between the ploidy pattern and clinicopathologic findings was studied, and the prognostic significance of the ploidy pattern was investigated. An aneuploid pattern was seen in 50% of the lesions with histologic embryonal and anaplastic types. It was not seen in the fetal type. In the tumors with combined epithelial components, the fetal-type component had a diploid pattern in all five cases. The embryonal-type component was associated with aneuploidy in two of five cases. In aneuploid tumors, vascular invasion (tumor emboli in the vessels) was observed more frequently. The prognosis of the patients with an aneuploid tumor was significantly poorer. These results indicate that nuclear DNA ploidy pattern analysis might be useful in investigating the prognosis of hepatoblastoma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657362     DOI: 10.1002/1097-0142(19911215)68:12<2566::aid-cncr2820681206>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  Apoptotic protein expression, glycogen content, DNA ploidy and cell proliferation in hepatoblastoma subtyping and their role in prognostication.

Authors:  Anita Chopra; Venkateswaran K Iyer; Sandeep Agarwala; Sandeep R Mathur; Manju Aron; Siddharth Datta Gupta; Kusum Verma
Journal:  Pediatr Surg Int       Date:  2010-08-28       Impact factor: 1.827

2.  Comparative DNA analysis by image cytometry and flow cytometry in non-small cell lung cancer.

Authors:  T Yamamoto; H Horiguchi; H Kamma; M Noro; T Ogata; Y Inage; E Akaogi; K Mitsui; M Hori; M Isobe
Journal:  Jpn J Cancer Res       Date:  1994-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.